Moderna, Inc. (0QF)
XETR
118.40
-11.70 (-8.99%)
Closed
Aug 24, 2026
Day's Range
111.42126.58
52 wk Range
19.37142.38
Financial Statements - 0QF - Moderna, Inc.
Revenue
1.92B▼ 28.7%
Net Income
-2.82B▲ 5.9%Net Margin -146.8%
EBITDA
-2.53B▲ 9.7%
Free Cash Flow
-2.07B▲ 39.3%
Income Statement
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|---|---|
| Sales | 1.92B | 2.69B | 6.75B | 18.87B | 17.73B | 274M |
| Cost of Goods | 868M | 1.23B | 4.69B | 5.41B | 2.61B | 8M |
| Gross Profit | 1.05B | 1.46B | 2.06B | 13.45B | 15.11B | 266M |
 Operating Expense | - | - | - | - | - | - |
| Operating Income | -3.07B | -3.32B | -4.23B | 9.42B | 13.29B | -763M |
| Non-Operating Interest | - | - | - | - | - | - |
| Other Income Expense | 2M | -53.07M | -86M | -16M | -29M | -6M |
| Pre Tax Income | -2.76B | -3.03B | -3.94B | 9.57B | 13.28B | -744M |
| Income Tax | 54M | -38.75M | 772M | 1.21B | 1.08B | 3M |
| Net Income | -2.82B | -2.99B | -4.71B | 8.36B | 12.20B | -747M |
| EPS Basic | -7.26 | -9.28 | -12.33 | 21.26 | 30.31 | -1.96 |
| EPS Diluted | -7.26 | -9.28 | -12.33 | 20.12 | 28.29 | -1.96 |
| Basic Shares Outstanding | 389M | 323.48M | 400.92M | 413.06M | 422.50M | 399.78M |
| Diluted Shares Outstanding | 389M | 323.48M | 400.92M | 413.06M | 422.50M | 399.78M |
| Ebit | -2.75B | -3.01B | -3.90B | 9.60B | 13.29B | -763M |
| Ebitda | -2.53B | -2.81B | -3.21B | 9.97B | 13.52B | -732M |
| Net Income Continuous Operations | -2.82B | -2.99B | -4.71B | 8.36B | 12.20B | -747M |
| Minority Interests | - | - | - | - | - | - |
| Preferred Stock Dividends | - | - | - | - | - | 0 |
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
